New York County Supreme Court — Commercial Division
60 Centre St, New York, NY 10007
Court websiteNew York · Zantac claim: what to ask and what to do
Zantac claim: what to ask and what to do in New York
See If You Qualify
Free · No obligation · About 2 minutes
| Filing deadline | 3 years from date of cancer diagnosis discovery (Frye expert standard — favorable)CPLR § 214-c |
|---|
Deadlines vary with the facts of each case. A lawyer can confirm yours.
Updated
01 · Your filing deadline
What is the deadline in New York?
New York has a 3-year statute of limitations for toxic substance personal injury claims (CPLR § 214-c), which is more favorable than the 2-year period in most states. The discovery rule applies. New York uses the Frye standard for novel expert testimony (People v. Wesley, 83 N.Y.2d 417), asking whether the scientific methodology is generally accepted in the relevant community. A lawyer can confirm yours.
3 years from date of cancer diagnosis discovery (Frye expert standard — favorable)
This standard, similar to Delaware's, is potentially more permissive than the federal Daubert standard that caused the MDL dismissal.
Source: CPLR § 214-c
Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.
02 · Where cases are heard
Where would my case be heard?
New York offers a more favorable 3-year statute of limitations for toxic exposure cases under CPLR § 214, giving Zantac claimants additional time compared to most states. New York uses the Frye standard for novel scientific evidence — the same general acceptance standard used in Delaware — making expert admissibility in New York state courts potentially more favorable than in Daubert jurisdictions. New York City's court system is one of the most sophisticated in the country for complex pharmaceutical litigation.
Statute of Limitations — NY (3 years): New York imposes a 3-year statute of limitations for personal injury under CPLR § 214, running from discovery of the injury. New York's discovery rule is narrowly construed — courts look to when plaintiffs had knowledge of facts sufficient to suggest a causal connection to ranitidine/NDMA. The FDA's April 2020 nationwide recall of all ranitidine products is frequently cited as the constructive discovery date for plaintiffs who had not previously connected their diagnosis to Zantac use, though courts may look to earlier individualized facts. Plaintiffs with diagnosed cancers — particularly bladder, esophageal, stomach, colorectal, liver, pancreatic, breast, or lung — should consult counsel to preserve claims.
U.S. District Court, Southern District of New York
500 Pearl St, New York, NY 10007
Court websiteMedical facilities in New York
Memorial Sloan Kettering Cancer Center
Roswell Park Comprehensive Cancer Center
How this works nationally
For the overall process and updates, read the Zantac claim: what to ask and what to do overview. This page covers the local information available for New York.
What happens when I check?
You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.
Live in New York? Read what applies in your state.
Register your interest. If a participating law firm takes these cases, it may contact you.
Register your interestSources
- CPLR § 214-c